Breaking News

Dollar Tree Agrees to Buy Family Dollar for $74.50 a Share

Regeneron Announces Upcoming 2014 Investor Conference Presentations

     Regeneron Announces Upcoming 2014 Investor Conference Presentations  PR Newswire  TARRYTOWN, N.Y., Feb. 14, 2014  TARRYTOWN, N.Y., Feb.14, 2014 /PRNewswire/ --Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:    o2014 RBC Capital Markets' Global Healthcare Conference at 10:00 a.m.     Eastern Time on Tuesday, February 25, 2014   oCowen and Company 34^th Annual Healthcare Conference at 1:30 p.m. Eastern     Time on Monday, March 3, 2014   oBarclays Global Healthcare Conference at 1:00 p.m. Eastern Time on     Tuesday, March 11, 2014  The sessions may be accessed through the Company's web site,, on the 'Events and Presentations' page. Archived versions of the presentations will be available for 30 days.  About Regeneron Pharmaceuticals Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma, and atopic dermatitis. For additional information about the company, please visit  Contact Information: Manisha Narasimhan, Ph.D.                    Peter Dworkin Investor Relations    Corporate Communications 914.847.5126 914.847.7640                SOURCE Regeneron Pharmaceuticals, Inc.  Website: